TIPE2 has recently been considered a key negative regulator of immune and inflammation homeostasis, which is closely associated with cancer development and progression.13, 14, 15 The expression levels of TIPE2 in normal tissues and tumours are of high specificity in both humans and mice. This evidence concerns the gene TIPE2 and neoplasm.